When myeloma cells develop into a single collection of cells, typically in the bone, it is called a solitary plasmacytoma. Multiple myeloma refers to the presence of several myeloma tumors. MGUS (monoclonal gammopathy of uncertain significance) and smoldering myeloma cause no symptoms but refer to the development of abnormal cells that can eventually lead to multiple myeloma or related cancers.
Unique Cell Therapy Options for Multiple Myeloma
Duke is one of the few centers to offer Tecvayli® and Talvey®, the first treatments of their kind for multiple myeloma. These special proteins -- called bispecific antibodies -- help your immune system recognize the multiple myeloma cells in your body and destroy them.
Rare, Related Diseases
We also treat rare diseases related to myeloma, including:
- POEMS syndrome
- Light or heavy chain deposition disease
- Waldenstrom's macroglobulinemia, a form of lymphoma
Personalized Treatment Plan
We design a personalized treatment plan that is right for you. For example, if you are experiencing smoldering myeloma or MGUS, which typically do not produce symptoms, we may recommend active surveillance of your myeloma. Young, healthy people with symptoms may tolerate more intensive therapies, while older or frail people may benefit from gentler treatment options.
We Work With Your Doctors
We routinely see people who travel to Duke for consultations and work with physicians near your home to ensure you receive the optimal care for your stage and type of myeloma.